文献速递脑血管病

铁状态与卒中风险

Iron Status and Risk of Stroke.
PubMed 文献 · Stroke · 2018-01-01

本研究采用孟德尔随机化方法,利用铁状态遗传学联盟在48972名受试者中识别的与4项铁状态生物标志物相关的遗传变异作为工具变量,并结合MEGASTROKE联盟的遗传估计,探讨遗传决定的铁状态与卒中风险的关联。主要分析显示,遗传决定的铁状态升高与卒中风险增加相关,且这种不利效应主要由心源性栓塞性卒中驱动。

要点

  • 遗传决定的铁状态升高与卒中风险增加相关(血清铁OR 1.07)。
  • 铁蛋白(经对数转换)OR 1.18、转铁蛋白饱和度OR 1.06,均与卒中风险增加相关。
  • 转铁蛋白升高(提示铁状态较低)与卒中风险降低相关(OR 0.92)。

核心结论

  • 本研究提供孟德尔随机化证据表明,较高的铁状态与卒中风险增加相关,尤其是心源性栓塞性卒中;需进一步研究其潜在机制以及是否可在预防策略中作为靶点。

研究设计与样本

  • 采用孟德尔随机化技术,利用铁状态遗传学联盟在48972名受试者中识别的与血清铁、转铁蛋白饱和度、铁蛋白和转铁蛋白4项生物标志物具有一致关系的遗传变异作为整体铁状态的工具变量。
  • 采用MEGASTROKE联盟的遗传估计,研究相同遗传变异与卒中风险的关联;主要分析采用两样本比值法孟德尔随机化方法,敏感性分析采用MR-Egger和加权中位数技术。

主要发现

  • 主要结果以遗传决定的铁状态生物标志物每增加1个标准差单位对应的卒中比值比(OR)表示:血清铁OR 1.07(95%CI 1.01-1.14),铁蛋白(经对数转换)OR 1.18(95%CI 1.02-1.36),转铁蛋白饱和度OR 1.06(95%CI 1.01-1.11)。
  • 转铁蛋白升高(提示铁状态较低)与卒中风险降低相关(OR 0.92,95%CI 0.86-0.99)。
  • 在缺血性卒中亚型分析中,铁状态的不利效应主要由心源性栓塞性卒中驱动。
  • 上述结果在更能耐受多效性变异纳入的统计敏感性分析中得到支持。

局限性

  • 原文结论指出,需进一步研究其潜在机制以及是否可在预防策略中作为靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- Both iron deficiency and excess have been associated with stroke risk in observational studies. However, such associations may be attributable to confounding from environmental factors. This study uses the Mendelian randomization technique to overcome these limitations by investigating the association between genetic variants related to iron status and stroke risk. Methods- A study of 48 972 subjects performed by the Genetics of Iron Status consortium identified genetic variants with concordant relations to 4 biomarkers of iron status (serum iron, transferrin saturation, ferritin, and transferrin) that supported their use as instruments for overall iron status. Genetic estimates from the MEGASTROKE consortium were used to investigate the association between the same genetic variants and stroke risk. The 2-sample ratio method Mendelian randomization approach was used for the main analysis, with the MR-Egger and weighted median techniques used in sensitivity analyses. Results- The main results, reported as odds ratio (OR) of stroke per SD unit increase in genetically determined iron status biomarker, showed a detrimental effect of increased iron status on stroke risk (serum iron OR, 1.07; 95% CI, 1.01-1.14; [log-transformed] ferritin OR, 1.18; 95% CI, 1.02-1.36; and transferrin saturation OR, 1.06; 95% CI, 1.01-1.11). A higher transferrin, indicative of lower iron status, was also associated with decreased stroke risk (OR, 0.92; 95% CI, 0.86-0.99). Examining ischemic stroke subtypes, we found the detrimental effect of iron status to be driven by cardioembolic stroke. These results were supported in statistical sensitivity analyses more robust to the inclusion of pleiotropic variants. Conclusions- This study provides Mendelian randomization evidence that higher iron status is associated with increased stroke risk and, in particular, cardioembolic stroke. Further work is required to investigate the underlying mechanism and whether this can be targeted in preventative strategies.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Gill D, Monori G, Tzoulaki I, et al. Iron Status and Risk of Stroke. Stroke. 2018. PMID: 30571402. doi:10.1161/STROKEAHA.118.022701

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。